PMID: 6104635Jan 1, 1980Paper

Electrophysiological characteristics of tobanum, a new beta receptor blocking agent

International Journal of Clinical Pharmacology, Therapy, and Toxicology
F Solti, E Czakó

Abstract

The electrophysiological properties of Tobanum (a new beta receptor blocking drug) were studied in 14 patients by the aid of His electrography and programmable electrical stimulation of the heart. On the effect of Tobanum (0,9 mg by slow i.v. injection), three characteristic changes could be detected: 1. The impulse conduction in AV node slowed down markedly. 2. The heart frequency decreased. 3. The effective refractory period of the atrium significantly increased. Tobanum seems to be a very effective antiarrhythmic drug for the treatment of supraventricular tachycardias.

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.